Japanese MHLW approves ADCETRIS for relapsed or refractory CD30-positive HL and ALCL


Posted in: Medical Condition News | Pharmaceutical News

Tags: Anaphylaxis, Anemia, Antibodies, Antibody, Biopsy, Biotechnology, Blood, Brain, Brentuximab Vedotin, Cancer, Cell, Chemotherapy, Cough, Diarrhea, Fever, Genetics, Hodgkin Lymphoma, Immunosuppression, Lymphoma, Monoclonal Antibody, Nausea, Nervous System, Neuropathic Pain, Neuropathy, Neutropenia, New Drug Application, Pain, Peripheral Neuropathy, Pfizer, Pneumonia, Respiratory, Sepsis, Stem Cell, technology, Thrombocytopenia, Transplant, Tumor, Virus, Vomiting